CION Ameerpet
Flow cytometry checks the marker "fingerprint" on your cells to help identify whether lymphoma is present and which type. This guide explains what the test measures, which markers matter, and how CION's team turns those results into a clear diagnosis.
Flow cytometry is a laboratory test that looks at your cells one at a time. Cells from a sample are tagged with fluorescent antibodies and then streamed, single-file, past a laser. As each cell passes, the machine records which marker proteins it carries — building a precise "fingerprint" of the cell population in seconds. In lymphoma, this fingerprint helps separate normal lymph node or blood cells from an abnormal, single-clone population, and it starts to point toward which lymphoma type is present.
The technical name for reading these markers is immunophenotyping — identifying a cell by its immune "phenotype", the pattern of proteins on and inside it. Flow cytometry is the main way immunophenotyping is done on liquid or fresh samples; the same idea is applied on solid tissue using immunohistochemistry. The proteins themselves are described by lymphoma cell markers — the "CD" numbers you may see on a report.
Flow cytometry is one important step in a wider work-up. For the full picture, see our lymphoma hub, our page on how doctors identify which lymphoma subtype you have, and — once a subtype is confirmed — lymphoma treatment in Hyderabad.
A single flow cytometry run can measure several markers on thousands of cells per second, and modern clinical instruments routinely assess 8 to 10 markers at once on every cell. That is why flow cytometry can quickly flag a subtle abnormal (clonal) lymphocyte population in the blood or marrow that would be hard to spot by eye. (Source: principles of clinical flow cytometry, as applied in NCCN and ESMO lymphoma diagnostic guidance.)
Lymphoma is not one disease — it is dozens of subtypes that look similar under the microscope but behave and respond very differently. Reading the cell markers is how the pathologist tells them apart.
The first fork in the road. Flow cytometry shows whether the abnormal cells are B lymphocytes or T lymphocytes — a distinction that shapes the entire diagnostic pathway and the eventual treatment approach.
A reactive (normal) immune response is a mixed crowd of cells. A lymphoma is usually a single clone. In B cells, light-chain restriction — every abnormal cell carrying the same kappa or lambda light chain — is a strong clue that the population is clonal.
Specific marker combinations narrow a broad group down toward a named subtype. This feeds directly into your pathology report and, ultimately, the treatment plan.
We plan the biopsy and flow cytometry together so a fresh portion of the sample reaches the lab correctly. A haematopathologist then integrates every result into a single, clear diagnosis.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Waiting on flow cytometry results, or unsure what the markers on your report mean? CION's lymphoma team will explain them and tell you what happens next.
The process turns a messy mixture of cells into a clear read-out of what is present:
Because the test needs living, intact cells, the fresh sample must reach the lab promptly and in the right medium. This is why CION coordinates the biopsy and lab steps together — and why an excisional (whole-node) biopsy or a well-planned core needle biopsy is preferred over a tiny fine-needle sample.
These are testing concepts, not a diagnosis in themselves — the meaning of any single marker depends on the whole pattern, read by a specialist.
| Marker | Broadly indicates | Why it matters |
|---|---|---|
| CD45 | White blood cells (leukocytes) | Helps separate white cells from other cells in the sample |
| CD19, CD20, CD22 | B lymphocytes | Confirm B-cell lineage; some are also therapy targets |
| CD3, CD4, CD8 | T lymphocytes | Confirm T-cell lineage and sub-populations |
| Kappa / Lambda | Light-chain restriction | A single dominant light chain suggests a clonal (abnormal) B-cell population |
| CD5, CD10, CD23 | Subtype clues | Combinations help distinguish one B-cell subtype from another |
| CD30 | Certain lymphoma cells | A marker relevant to some subtypes and to antibody-based therapy decisions |
Markers and their significance vary by individual case. This table is a general guide only; interpretation follows the WHO classification and NCCN/ESMO guidance, and is always made by a qualified haematopathologist on the full result set.
Flow cytometry is fast and superb at detecting and characterising cells in liquid samples — blood, bone marrow and fluids. But a complete lymphoma diagnosis also needs the tissue architecture: how the cells are arranged within the lymph node. That structural information only comes from examining the biopsy tissue itself.
So flow cytometry is used together with:
One important example: classic Hodgkin lymphoma often has very few tumour cells scattered in a sea of normal cells, so it may not show up well on flow cytometry and is diagnosed mainly on tissue and IHC. This is exactly why NCCN and ESMO recommend integrating flow cytometry with tissue morphology rather than relying on any single test. See how the results come together on how doctors identify which lymphoma subtype you have.
Getting the subtype right is not academic — it drives outcomes. With accurate diagnosis and modern, guideline-based treatment, published series report roughly 80–90% long-term survival for Hodgkin lymphoma and around 60–70% for diffuse large B-cell lymphoma, the most common aggressive non-Hodgkin type. Figures vary considerably by individual, stage and subtype. (Source: figures consistent with published outcome series referenced by NCCN and ESMO lymphoma guidelines.)
Flow cytometry rarely stands alone — it runs as one part of a coordinated pathway designed to reach an accurate diagnosis quickly, without repeat biopsies:
When lymphoma is suspected, the biopsy is planned so a fresh portion goes for flow cytometry while the rest is fixed for morphology and immunohistochemistry. This "test once, test right" approach is why sample handling is coordinated up front.
The marker pattern from flow cytometry is read together with the tissue findings. Where a subtype needs confirming, molecular and genetic tests are added. A haematopathologist integrates everything into one diagnosis rather than a stack of separate results.
The confirmed subtype and stage are discussed at a multidisciplinary tumour board before any plan is set. CION delivers chemotherapy, antibody-based immunotherapy, targeted therapy and precision radiation (IMRT) directly; where a specialised procedure such as a stem-cell transplant is indicated, it is coordinated through accredited partner facilities. Treatment specifics are covered on our lymphoma treatment in Hyderabad page.
To meet the team, see the best lymphoma doctors in Hyderabad and the best lymphoma hospital in Hyderabad.
Lymphoma subtyping carries real nuance, and a second look is especially worthwhile when:
CION offers a dedicated, free written second-opinion service. You deserve a plan built around healing, not billing — with transparent costs explained up front. Request your free second opinion or call 18002028726.
Get a free written second opinion from CION's lymphoma team — especially valuable if flow cytometry, immunohistochemistry or molecular testing has not yet been fully arranged.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Flow cytometry is a laboratory test that examines individual cells one at a time as they flow past a laser. It measures the proteins (called markers) on the surface and inside each cell, giving a rapid, detailed "fingerprint" of the cells in a sample. In lymphoma, flow cytometry helps tell normal lymph node or blood cells apart from an abnormal (clonal) population, and it starts to point toward which type of lymphoma is present. It works best on liquid or fresh samples — blood, bone marrow, or fresh biopsy tissue and fluids. Flow cytometry is one part of a full diagnostic work-up; it is usually read alongside immunohistochemistry on the biopsy tissue and reviewed by a haematopathologist. Learn how the pieces fit together on our how your lymphoma subtype is identified page.
Immunophenotyping means identifying a cell by the pattern of markers it carries — its immune "phenotype". Flow cytometry is the main tool used to do immunophenotyping on liquid samples, but the same idea is also applied on tissue using immunohistochemistry (IHC). So immunophenotyping is the goal, and flow cytometry is one of the methods. In practical terms, immunophenotyping lymphoma tells the pathologist whether the abnormal cells are B cells or T cells, whether they look mature or immature, and whether they form a single abnormal clone. That marker pattern narrows a broad group of possibilities down toward a specific subtype, which then guides staging and treatment. The results feed directly into your pathology report.
Flow cytometry checks a panel of lymphoma cell markers — proteins labelled "CD" (cluster of differentiation) numbers. Common B-cell markers include CD19, CD20, CD22 and CD5; T-cell markers include CD3, CD4 and CD8; and CD45 helps separate white blood cells from other cells. A key finding in B-cell lymphoma is light-chain restriction — when the abnormal B cells all carry the same kappa or lambda light chain, signalling they came from one clone rather than a normal, mixed immune response. Markers such as CD10 and CD23 help distinguish subtypes further. Certain markers (for example CD20 or CD30) are also relevant because they can be targeted by antibody-based therapy — though the specific treatment is decided separately and is covered on our lymphoma treatment page.
Usually not on its own. Flow cytometry is fast and powerful at detecting and characterising abnormal cells, especially in blood, bone marrow and fluids, but a full lymphoma diagnosis needs the tissue architecture too — how the cells are arranged within the lymph node. That is why an excisional (whole-node) biopsy is preferred, and why flow cytometry is combined with immunohistochemistry and, when needed, molecular and genetic testing. Some lymphomas — classic Hodgkin lymphoma is the classic example — have very few tumour cells scattered in the node, so they may not show up well on flow cytometry and are diagnosed mainly on tissue and IHC. NCCN and ESMO guidance both recommend integrating flow cytometry with tissue morphology rather than relying on it alone.
Flow cytometry needs cells in a liquid or fresh form: a blood sample, a bone marrow aspirate, fluid drained from around the lung or abdomen, or a fresh piece of a lymph node biopsy sent to the lab unfixed. A blood draw feels like any routine blood test. When a node or marrow sample is taken, local anaesthetic is used to numb the area, so most people feel pressure rather than sharp pain. It is important that the biopsy team knows flow cytometry is wanted, because a portion of the fresh sample must be set aside promptly in the right medium — fixed tissue alone cannot be used for standard flow cytometry. At CION the biopsy and laboratory steps are coordinated so the right samples reach the right test the first time.
Flow cytometry itself is relatively quick — a preliminary read can often be available within about 24 to 48 hours of the lab receiving a good sample, which is one reason it is valued when a fast answer is needed (for example in a very unwell patient or when leukaemia is suspected in the blood). However, the final lymphoma diagnosis usually waits for the complete picture: tissue morphology, immunohistochemistry, and sometimes molecular tests, which together take several more days. Turnaround varies between laboratories and with how complex the case is. If you are waiting on results, our team can talk you through what has been done and what is still pending — book a free consultation to review your reports.
Flow cytometry is one step in a coordinated diagnostic pathway. Typically it runs in parallel with the biopsy: a fresh portion of the sample goes for flow cytometry while the rest is processed for morphology and immunohistochemistry. Blood tests such as LDH and imaging round out the assessment, and molecular studies are added when a subtype needs confirming. At CION, a haematopathologist integrates all of these into a single, clear diagnosis, and the case is discussed at a multidisciplinary tumour board before any treatment plan is set. This "test once, test right" approach avoids repeat biopsies and delays. You can read the wider testing journey on our lymphoma hub and see how a confirmed subtype leads into care on our lymphoma treatment in Hyderabad page.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.